Skip to content

Insider · CIK 0001161662

RIEDEL NORBERT G

Reports to the SEC for 8 companies · DUBLIN 4

Transactions

50

Companies

8

Filings

9

CIK

0001161662

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-08-31JAZZJazz Pharmaceuticals plcF Tax Payment−$3,425.02
2026-08-31JAZZJazz Pharmaceuticals plcF Tax Payment−$408K
2026-08-05JAZZJazz Pharmaceuticals plcA Award—
2026-07-31ETONEton Pharmaceuticals, Inc. · Common StockA Award—
2026-04-21ETONEton Pharmaceuticals, Inc.M Exercise/Conversion+$91.4K
2026-04-21ETONEton Pharmaceuticals, Inc.M Exercise/Conversion+$169K
2026-04-21ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2026-04-21ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2026-02-27JAZZJazz Pharmaceuticals plcM Exercise/Conversion+$472K
2026-02-27JAZZJazz Pharmaceuticals plcS Sale−$656K
2026-02-27JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion—
2026-02-03ETONEton Pharmaceuticals, Inc.X Exercise of In-Money+$133K
2026-02-03ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)X Exercise of In-Money—
2026-01-12ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award—
2026-01-12ETONEton Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2025-08-08JAZZJazz Pharmaceuticals plcF Tax Payment−$201K
2025-08-07JAZZJazz Pharmaceuticals plcA Award—
2025-01-03ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)A Award—
2025-01-03ETONEton Pharmaceuticals, Inc.M Exercise/Conversion+$98.1K
2025-01-03ETONEton Pharmaceuticals, Inc.M Exercise/Conversion+$189K
2025-01-03ETONEton Pharmaceuticals, Inc.M Exercise/Conversion+$86.8K
2025-01-03ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2025-01-03ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2025-01-03ETONEton Pharmaceuticals, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2024-08-06JAZZJazz Pharmaceuticals plcF Tax Payment−$165K
2024-08-02JAZZJazz Pharmaceuticals plcA Award—
2024-08-01Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer—
2024-08-01Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer—
2024-08-01Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2024-06-05Cerevel Therapeutics Holdings, Inc.A Award—
2024-02-13ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award—
2023-08-14JAZZJazz Pharmaceuticals plcS Sale−$171K
2023-08-11JAZZJazz Pharmaceuticals plcA Award—
2023-06-07Cerevel Therapeutics Holdings, Inc.A Award—
2023-06-07Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award—
2023-03-03ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award—
2023-01-03Aptinyx Inc.Stock Option (Right to Buy)A Award—
2022-08-08JAZZJazz Pharmaceuticals plcS Sale−$166K
2022-08-05JAZZJazz Pharmaceuticals plcM Exercise/Conversion+$442K
2022-08-05JAZZJazz Pharmaceuticals plcS Sale−$1.25M
2022-08-05JAZZJazz Pharmaceuticals plcA Award—
2022-08-05JAZZJazz Pharmaceuticals plc · Non-Qualified Stock Option (right to buy)M Exercise/Conversion—
2022-06-14Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award—
2022-02-07ETONEton Pharmaceuticals, Inc. · Stock Option (Right to buy)A Award—
2022-01-04Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion—
2022-01-04Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion—
2021-12-06Aptinyx Inc.P Purchase+$223K
2021-12-02Aptinyx Inc.Stock Option (Right to Buy)A Award—
2021-08-06JAZZJazz Pharmaceuticals plcS Sale−$193K
2021-07-29JAZZJazz Pharmaceuticals plcA Award—